Study of heart inflammation after COVID-19 vaccination in Norway
Part of Heart & circulation clinical trials.
This study looks at people who may have developed myocarditis or pericarditis (inflammation of the heart muscle or the lining around the heart) shortly after a COVID-19 vaccine. It compares their health records to vaccination records to understand who is affected and when, which may help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had myocarditis or pericarditis that was confirmed as definite, probable, or possible.
- Your symptoms/diagnosis happened within 90 days after a COVID-19 vaccine.
- Your case is identified through Norway health registries, using diagnosis records and vaccination records.
- The study looks for cases where the vaccine could be a likely cause.
- People with a more likely cause (especially COVID-19 infection) are not included.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a “registry,” meaning it collects medical information about people who develop possible heart inflammation after a COVID-19 vaccine. It may help doctors understand how often this happens and which findings are linked to it.
This study is collecting information from people who have had chest pain but no blockages in their heart arteries, to better understand a condition called myocarditis. Participating means allowing researchers to review your health records and possibly answer questions.
This study uses a special heart MRI to look closely at inflammation in the heart muscle. It helps doctors better understand and treat myocarditis and inflammatory cardiomyopathy.
This study collects information from people with newly diagnosed acute myocarditis using heart scans and, in some cases, a biopsy. It aims to understand what predicts recovery and which test results matter most for outcomes.
This study looks back at people who were hospitalized for myocarditis (inflammation of the heart muscle) to see if a special measurement of blood flow in the tiny heart vessels can predict how well they do over the next year. The findings might help doctors better understand and treat this condition.
This study looks at genetic information to better understand why some people develop serious side effects after a COVID-19 vaccine, such as GBS, blood clotting with low platelets (VITT/TTS), or heart inflammation (myocarditis/pericarditis). Your information may help researchers learn who is at higher risk and improve future safety.
Hear when a new Myocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.